Johns Hopkins scientist wins $2.5M NIH Director’s Set Grant
A Johns Hopkins scientist who proposes to pattern and produce an all-new series of narrative drugs is at one of 17 winners of a in a class by itself endowment known as a Director’s Develop Grant from the Governmental Institutes of Fettle.
The accord, to Jun O. Liu, Ph.D., a professor of pharmacology and molecular sciences and oncology in the Johns Hopkins University Kind of Medication, carries $2.5 million in study buttress to five years.
As impresario of the Johns Hopkins Cure Library, which houses 3,000 of the estimated 10,000 drugs second-hand in medical exactness, Liu has specialized in determination unique uses fit often-forgotten drugs. Quantity the big name discoveries was that a known antifungal antibiotic, itraconazole, is a authoritative inhibitor of angiogenesis, or strange blood container founding, implicated in cancer, macular degeneration and other diseases. Based on that decree, itraconazole has entered multiple Gradually eliminate 2 clinical studies quest of jocular tummy rot cancer at the Johns Hopkins Sidney Kimmel Extensive Cancer Center and absent.
Liu also start that an antediluvian antibiotic, clofazimine, adapted to more than a century ago to medicate leprosy, may be possessions against autoimmune disorders multiple sclerosis and psoriasis. Most recently, he screened 175,000 unoriginal chemical compounds and identified a league of them that potently and selectively slows down the work of a protein compulsory to the evolution of tuberculosis. The navy showed that the protein is a defenceless poison objective also in behalf of TB.
Help-Medical.net finds at this phrases:
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
